|
FY2025
12 months to Nov 30, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Nov 30, 2023
|
FY2022
12 months to Nov 30, 2022
|
FY2021
12 months to Nov 30, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net Income | |||||
| Adjustments to reconcile net income to cash flows provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred tax | |||||
| Provision for credit losses, net of recoveries | |||||
| Noncash lease expense | |||||
| Sales-type lease income | |||||
| Loss on sales-type lease termination | |||||
| Trade accounts receivable and notes receivable | |||||
| Marketing fund contributions receivable | |||||
| Prepaid expenses and other | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Unexpended marketing fund contributions | |||||
| Deferred revenue | |||||
| Operating lease liability | |||||
| Net Cash Provided by Operating Activities | |||||
| Purchase of equipment | |||||
| Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | |||||
| Capitalized trademark costs | |||||
| Sale of equipment | |||||
| Asset purchase | |||||
| Proceeds from sale of asset | |||||
| Issuance of note receivable | |||||
| Net Cash Used In Investing Activities | |||||
| Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | |||||
| Cash distributions/dividends | |||||
| Net Cash Used In Financing Activities | |||||
| Net Increase in Cash and Restricted Cash | |||||
| Cash and Restricted Cash - Beginning of Period | |||||
| Cash and Restricted Cash - End of Period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Net investment in lease receivable | |||||
| Other Noncash Investing and Financing Items | |||||
| Asset held for resale offsetting lease termination loss | |||||
| Right-of-use operating asset obtained in exchange for operating lease liability | |||||
Loading...